NCT05453903 2026-04-13A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed TherapiesJanssen Research & Development, LLCPhase 1 Active not recruiting196 enrolled
NCT07007312 2026-04-09Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLKura Oncology, Inc.Phase 3 Recruiting1,300 enrolled